Media coverage
5
Media coverage
Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid Tumors Media name/outlet MarketScreener.com Country/Territory United States Date 9/01/20 URL https://www.marketscreener.com/news/Oxford-BioTherapeutics-Initiates-Dose-Escalation-Portion-of-U-S-Phase-I-Clinical-Trial-for-OBT076-i--29812503/ Persons Gary Schwartz Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid Tumors Media name/outlet Jotup Country/Territory United States Date 9/01/20 URL https://jotup.co/node/614795 Persons Gary Schwartz Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid Tumors Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 9/01/20 Persons Gary Schwartz Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid Tumors Media name/outlet GlobeNewswire Country/Territory United States Date 9/01/20 URL https://www.globenewswire.com/news-release/2020/01/09/1968409/0/en/Oxford-BioTherapeutics-Initiates-Dose-Escalation-Portion-of-U-S-Phase-I-Clinical-Trial-for-OBT076-in-Patients-with-Advanced-Solid-Tumors.html Persons Gary Schwartz Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid Tumors Media name/outlet Erie News Now Country/Territory United States Date 9/01/20 URL www.erienewsnow.com/story/41541566/oxford-biotherapeutics-initiates-dose-escalation-portion-of-us-phase-i-clinical-trial-for-obt076-in-patients-with-advanced-solid-tumors Persons Gary Schwartz